AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 9247942
Drug: 0.025 mg/kg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.025 mg/kg midazolam
Trial: 8005970
Drug: Steroid and
RxNorm normalized name: Corticosteroid and/or corticosteroid derivative
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Steroid and cyclophosphamide every other month (Gr-I)
Trial: 8005970
Drug: Steroid alone
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Steroid alone (Gr-II)
Trial: 3551327
Drug: Combined treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combined treatment (preoperative Co‐60 teletherapy + radical surgery)
Trial: 29093280
Drug: Weekly DPP‐4
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Weekly DPP‐4 inhibitor, trelagliptin
Trial: 29093280
Drug: Daily DPP‐4
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Daily DPP‐4 inhibitors
Trial: 23817470
Drug: 1.6 g
RxNorm normalized name: GLYCERIN 1241.6 g in 1 L TOPICAL LIQUID
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1.6 g DHA/day from a microalgae source with 2.4 g/day carrier oil for 16 weeks
Trial: 23817470
Drug: 4.0 g/day
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 4.0 g/day olive oil for 16 weeks (control)
Trial: 18323500
Drug: Clopidogrel plus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Clopidogrel plus aspirin (C+A)
Trial: 16581062
Drug: Cyclooxygenase‐2 inhibitor
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cyclooxygenase‐2 inhibitor parecoxib (n=20)
Trial: 12974197
Drug: Cyclosporine (CsA)
RxNorm normalized name: Cyclosporine
DrugBank: Cyclosporine (DB00091)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cyclosporine (CsA) 5 mg/kg per day for 8 weeks, then 4 mg/kg per day for 8 weeks
Trial: 9383258
Drug: Cetirizine 10
RxNorm normalized name: cetirizine 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cetirizine 10 mg/day
Trial: 12974197
Drug: Cyclosporine (CsA)
RxNorm normalized name: Cyclosporine
DrugBank: Cyclosporine (DB00091)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cyclosporine (CsA) 5 mg/kg per day for 8 weeks, then 4 mg/kg per day for 8 weeks (after initial treatment with antihistamines)
Trial: 26275718
Drug: Person-Centred Counselling
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Person-Centred Counselling (8 weekly sessions lasting up to 1 hour)
Trial: 26275718
Drug: Low-Intensity Cognitive
RxNorm normalized name: low-density polyethylene
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low-Intensity Cognitive Behavioural Therapy (up to 8 weeks of self-help resources with guided telephone support lasting 20-30 minutes each)
Trial: 8526167
Drug: Azelastine nasal
RxNorm normalized name: azelastine nasal
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Azelastine nasal spray (0.14 mg in each nostril twice a day)
Trial: 8526167
Drug: Ebastine tablets
RxNorm normalized name: ebastine
DrugBank: Ebastine (DB11742)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ebastine tablets (10 mg as a single night dose)
Trial: 1780092
Drug: Nimesulide (one
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nimesulide (one suppository twice a day for 7 days)
Trial: 1780092
Drug: Flurbiprofen (one
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Flurbiprofen (one suppository twice a day for 7 days)
Trial: 28736139
Drug: Stop TDF
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Stop TDF therapy
Trial: 28736139
Drug: Continue TDF
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Continue TDF therapy
Trial: 26953856
Drug: Mindfulness-based stress
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Mindfulness-based stress reduction program (8-week initial treatment plus a 10-month maintenance phase)
Trial: 21845596
Drug: Continuation haloperidol
RxNorm normalized name: Haloperidol
DrugBank: Haloperidol (DB00502)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Continuation haloperidol (0.5‐5 mg daily)
Trial: 21845596
Drug: Haloperidol (0.5‐5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Haloperidol (0.5‐5 mg daily)
Trial: 7596886
Drug: Oral ketamine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral ketamine (10 mg/kg)
Trial: 28783060
Drug: Nacadia® therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nacadia® therapy garden design
Trial: 25998500
Drug: Febuxostat (10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Febuxostat (10 mg daily)
Trial: 23003917
Drug: Initial periodontal
RxNorm normalized name: brigatinib
DrugBank: Brigatinib (DB12267)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Initial periodontal treatment (test group, n = 20)
Trial: 23003917
Drug: No periodontal
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No periodontal therapy (control group, n = 20)
Trial: 18716365
Drug: Valsartan monotherapy
RxNorm normalized name: Valsartan
DrugBank: Valsartan (DB00177)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Valsartan monotherapy (VM)
Trial: 18716365
Drug: Amlodipine monotherapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Amlodipine monotherapy (AM)
Trial: 18716365
Drug: Valsartan +
RxNorm normalized name: Valsartan
DrugBank: Valsartan (DB00177)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Valsartan + ACE inhibitor (VA)
Trial: 18716365
Drug: Amlodipine +
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Amlodipine + ACE inhibitor (AA)
Trial: 10319359
Drug: Vitamin E
RxNorm normalized name: Vitamin E
DrugBank: Vitamin E (DB00163)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Vitamin E (1000 IU daily)
Trial: 1890479
Drug: Intramuscular morphine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intramuscular morphine (IM)
Trial: 28259476
Drug: First-line AR-targeted
RxNorm normalized name: AR-9281
DrugBank: AR-9281 (DB06345)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: First-line AR-targeted therapy
Trial: 25538174
Drug: Stereotactic radiosurgery
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Stereotactic radiosurgery (SRS) followed by chemotherapy
Trial: 19380866
Drug: Upfront chemotherapy
RxNorm normalized name: menthol
DrugBank: Menthol (DB14123)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Upfront chemotherapy
Trial: 19366755
Drug: Fluoroscopic guidance
RxNorm normalized name: Fluoroacetic acid F-18
DrugBank: Fluoroacetic acid F-18 (DB15202)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fluoroscopic guidance for corticosteroid injections (n=32)
Trial: 19366755
Drug: Blind injections
RxNorm normalized name: Io-Blend
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Blind injections using landmarks (n=33)
Trial: 16937961
Drug: Caffeine-containing supplement
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Caffeine-containing supplement (SUPP; n = 17)
Trial: 15252161
Drug: 4 h
RxNorm normalized name: Type 4 H
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 4 h infusion of 120 g of mixed AAs
Trial: 15252161
Drug: 4 h
RxNorm normalized name: Type 4 H
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 4 h infusion of 50 g of L‐lysine
Trial: 15252161
Drug: 10 h
RxNorm normalized name: POLYGLYCERYL-10 HEXAOLEATE
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10 h infusion of 240 g of mixed AAs
Trial: 15252161
Drug: 4 h
RxNorm normalized name: Type 4 H
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 4 h infusion of 50 g of L‐lysine + L‐arginine (Lys‐Arg)
Trial: 22875883
Drug: No infusion
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No infusion (control)
Trial: 9036797
Drug: Intravenous cidofovir,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous cidofovir, 5 mg/kg of body weight, once weekly for 2 weeks and then once every other week
Trial: 9036797
Drug: Deferred treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Deferred treatment (no cidofovir until progression documented)
Trial: 9058613
Drug: Intravenous cidofovir
RxNorm normalized name: Cidofovir
DrugBank: Cidofovir (DB00369)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intravenous cidofovir
Trial: 9036797
Drug: Intravenous cidofovir
RxNorm normalized name: Cidofovir
DrugBank: Cidofovir (DB00369)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intravenous cidofovir with probenecid and saline hydration
Trial: 7639363
Drug: Ketorolac 60
RxNorm normalized name: ketorolac 60 MG/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ketorolac 60 mg intravenously
Trial: 7639363
Drug: Ibuprofen 800
RxNorm normalized name: ibuprofen 800 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ibuprofen 800 mg orally
Trial: 29129715
Drug: Adapted Diabetes
RxNorm normalized name: Diabetic Tussin EX
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Adapted Diabetes Prevention Program Group Lifestyle Balance (DPP GLB) intervention, details on dosage and duration not specified.
Trial: 29129715
Drug: Responsive adaptations
RxNorm normalized name: ethanol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Responsive adaptations during intervention delivery, details on dosage and duration not specified.
Trial: 27145396
Drug: Online Lee
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Online Lee Silverman Voice Treatment (LSVT LOUD)
Trial: 27145396
Drug: Face‐to‐face Lee
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Face‐to‐face Lee Silverman Voice Treatment (LSVT LOUD)
Trial: 27145396
Drug: Online treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Online treatment (nonmetropolitan cohort)
Trial: 27145396
Drug: Online treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Online treatment (metropolitan cohort)
Trial: 18374304
Drug: Face-to-face cognitive-behavioral
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Face-to-face cognitive-behavioral therapy (FTF-CBT)
Trial: 18374304
Drug: Telemedicine cognitive-behavioral
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Telemedicine cognitive-behavioral therapy (TV-CBT)
Trial: 11198206
Drug: Intravenous immunoglobulin
RxNorm normalized name: Intravenous immunoglobulin (IVIg)
DrugBank: Human immunoglobulin G (DB00028)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous immunoglobulin IgG, 0.4 g/kg body weight/day for 5 consecutive days, followed by single booster doses of 0.4 g/kg/day, once a month for 9 months
Trial: 11198206
Drug: Intravenous immunoglobulin
RxNorm normalized name: Intravenous immunoglobulin (IVIg)
DrugBank: Human immunoglobulin G (DB00028)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous immunoglobulin IgG
Trial: 8833099
Drug: 1 g/kg/day
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1 g/kg/day alcohol
Trial: 8833099
Drug: 2 g/kg/day
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2 g/kg/day alcohol
Trial: 8833099
Drug: 0 g/kg/day
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0 g/kg/day alcohol (control)
Trial: 1428567
Drug: 0.5% maleate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.5% maleate timolol, twice a day for 7 days
Trial: 6776576
Drug: (‐)‐deprenyl (5‐10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: (‐)‐deprenyl (5‐10 mg/day for 3 days)
Trial: 30308286
Drug: Daily breath
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Daily breath alcohol monitoring with reinforcement for alcohol-negative breath samples
Trial: 30308286
Drug: Daily breath
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Daily breath alcohol monitoring without reinforcement
Trial: 30308286
Drug: Transdermal alcohol
RxNorm normalized name: Alcohol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Transdermal alcohol monitoring
Trial: 30308286
Drug: Transdermal monitoring
RxNorm normalized name: iodine
DrugBank: Iodine (DB05382)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Transdermal monitoring
Trial: 25796293
Drug: Oxycodone with
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oxycodone with analgesia information sheet
Trial: 23389323
Drug: sertraline hydrochloride
RxNorm normalized name: sertraline hydrochloride
DrugBank: Sertraline (DB01104)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: sertraline hydrochloride (50 mg/d) + active tDCS (2‐mA anodal left/cathodal right prefrontal tDCS, twelve 30‐minute sessions)
Trial: 17069818
Drug: Irbesartan (IRB;
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Irbesartan (IRB; 300 mg/d) for 12 weeks
Trial: 17069818
Drug: Losartan (10(‐5)
RxNorm normalized name: losartan 12.5 MG
DrugBank: Losartan (DB00678)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Losartan (10(‐5) mol/L)
Trial: 17069818
Drug: LY311727 (10(‐5)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: LY311727 (10(‐5) mol/L)
Trial: 10194425
Drug: FAI +
RxNorm normalized name: Fludrocortisone acetate
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: FAI + G-CSF
Trial: 10194425
Drug: FAI +
RxNorm normalized name: Fludrocortisone acetate
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: FAI + ATRA + G-CSF
Trial: 10194425
Drug: FAI +
RxNorm normalized name: Fludrocortisone acetate
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: FAI + G-CSF + ATRA
Trial: 6106781
Drug: Isophosphamide with
RxNorm normalized name: Primatene with ephedrine Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Isophosphamide with mesnum (4 to 8 g/m2)
Trial: 25782657
Drug: Probiotic milk
RxNorm normalized name: PROBIOTIC
DrugBank: Bifidobacterium longum (DB19248)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Probiotic milk containing Lactobacillus rhamnosus GG, L acidophilus La-5, and Bifidobacterium animalis subsp. lactis Bb-12, administered from 36 weeks of gestation to 3 months postnatally.
Trial: 23787030
Drug: 8-weeks of
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 8-weeks of combination nicotine replacement therapy (NRT) in conjunction with brief counseling (SBIRT framework) (n=23)
Trial: 16855076
Drug: Lidocaine (4
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lidocaine (4 mg/kg; maximal dose 300 mg)
Trial: 16855076
Drug: Oxycodone/acetaminophen (10/650
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oxycodone/acetaminophen (10/650 mg)
Trial: 16855076
Drug: Active placebo
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Active placebo (diphenhydramine, 50 mg)
Trial: 10818327
Drug: remifentanil +
FDA approved: no
EMA approved: no
PMDA approved: no
Description: remifentanil + propofol (0.1 mg/kg/min)
Trial: 6623770
Drug: 5,000 units
RxNorm normalized name: Lapase, 1200 units-15,000 units-15,000 units oral capsule
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 5,000 units of subcutaneous heparin three hours preoperatively and every twelve hours thereafter for forty-eight hours
Trial: 6623770
Drug: Normal saline
RxNorm normalized name: Normal Saline Flush
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Normal saline injections in a similar manner
Trial: 17461902
Drug: docetaxel (T)
RxNorm normalized name: Docetaxel
DrugBank: Docetaxel (DB01248)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: docetaxel (T) 75 mg/m(2), epirubicin (E) 75 mg/m(2), cyclophosphamide (C) 500 mg/m(2) IV
Trial: 17461902
Drug: docetaxel (T)
RxNorm normalized name: Docetaxel
DrugBank: Docetaxel (DB01248)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: docetaxel (T) 100 mg/m(2), epirubicin (E) 100 mg/m(2), cyclophosphamide (C) 500 mg/m(2) IV
Trial: 15033849
Drug: Antibiotic use
RxNorm normalized name: Antibiotics for systemic use
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Antibiotic use in RSV infected children
Trial: 11243558
Drug: B&L pinch
FDA approved: no
EMA approved: no
PMDA approved: no
Description: B&L pinch gauge
Trial: 3593897
Drug: Sucralfate (2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sucralfate (2 g) before ketoprofen (50 mg)
Trial: 3593897
Drug: Ketoprofen (50
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ketoprofen (50 mg) alone
Trial: 3593897
Drug: Sucralfate (2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sucralfate (2 g) before indomethacin (50 mg)
Trial: 3593897
Drug: Indomethacin (50
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Indomethacin (50 mg) alone
Trial: 3593897
Drug: Sucralfate (2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sucralfate (2 g) before naproxen (500 mg)
Trial: 3593897
Drug: Naproxen (500
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Naproxen (500 mg) alone
Trial: 28476259
Drug: Prednisone (40
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Prednisone (40 mg orally for 4 days)
Trial: 24635755
Drug: Intravitreal ranibizumab
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravitreal ranibizumab (IVR) 0.5 mg + intravitreal triamcinolone acetonide (IVTA) 1 mg
Trial: 16548351
Drug: Sanqi tablet
RxNorm normalized name: Sanqi
DrugBank: Panax notoginseng root (DB14304)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sanqi tablet (SQT)
Trial: 12517464
Drug: Antidepressant (fluoxetine)
RxNorm normalized name: ANTIDEPRESSANTS
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Antidepressant (fluoxetine)
Trial: 29659187
Drug: Test formulation
RxNorm normalized name: mumps skin test antigen
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Test formulation of anastrozole 1.0-mg tablet
Trial: 29659187
Drug: Reference formulation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Reference formulation of anastrozole (Arimidex 1.0-mg tablet)
Trial: 25458048
Drug: Parecoxib 0.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Parecoxib 0.5 mg/kg
Trial: 25458048
Drug: Morphine 50
RxNorm normalized name: MORPHINE 50MG/NALTREXONE 2MG SA CAP
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Morphine 50 μg/kg
Trial: 22551976
Drug: Vitamin K
RxNorm normalized name: Vitamin K
DrugBank: Phylloquinone (DB01022)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vitamin K antagonists (VKA) treatment
Trial: 15699689
Drug: Fructo-oligosaccharide formula
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fructo-oligosaccharide formula (1.5 g/L)
Trial: 15699689
Drug: Fructo-oligosaccharide formula
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fructo-oligosaccharide formula (3.0 g/L)
Trial: 10446816
Drug: Acetazolamide 250
RxNorm normalized name: acetazolamide 250 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Acetazolamide 250 mg every 6 hrs for a total of four doses
Trial: 10446816
Drug: Acetazolamide 500
RxNorm normalized name: acetazolamide 500 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Acetazolamide 500 mg as a single dose
Trial: 7844602
Drug: Adoptive immunotherapy
RxNorm normalized name: Adoptive immunotherapy agent CTL019
DrugBank: Tisagenlecleucel (DB13881)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Adoptive immunotherapy with tumor-infiltrating lymphocytes (TIL) genetically modified with a retroviral vector containing the NeoR gene.
Trial: 2085872
Drug: Nitrate therapy
RxNorm normalized name: Nitrate
DrugBank: Nitrate (DB14049)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nitrate therapy (2 x 20 mg IS‐5‐MN and 1 x 120 mg ISDN sustained release)
Trial: 454092
Drug: MAO inhibitors
RxNorm normalized name: MAO inhibitors
FDA approved: no
EMA approved: no
PMDA approved: no
Description: MAO inhibitors
Trial: 22525398
Drug: Ribosome-component immune
RxNorm normalized name: Immune Globulin
DrugBank: Human immunoglobulin G (DB00028)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ribosome-component immune modulator (RCIM)
Trial: 16096858
Drug: Azithromycin (AZM)
RxNorm normalized name: Azithromycin
DrugBank: Azithromycin (DB00207)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Azithromycin (AZM) 250 mg twice a week for 12 weeks
Trial: 9951979
Drug: SB MMR
RxNorm normalized name: MMR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: SB MMR vaccine (Priorix; SmithKline Beecham Biologicals)
Trial: 9951979
Drug: Merck MMR
RxNorm normalized name: varicella-zoster virus vaccine live (Oka-Merck) strain Injection [Varivax]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Merck MMR vaccine (M‐M‐R II; Merck & Co. Inc)
Trial: 35211
Drug: Diazepam 5
RxNorm normalized name: diazepam 5 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Diazepam 5 mg three times daily
Trial: 29317191
Drug: Ramucirumab 10
RxNorm normalized name: ramucirumab 10 MG/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ramucirumab 10 mg/kg every 2 weeks with erlotinib 150 mg/d
Trial: 25679172
Drug: Intermediate dose
RxNorm normalized name: Prevotella intermedia
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intermediate dose calculation during optimization
Trial: 10871094
Drug: Serial doses
RxNorm normalized name: Echinacea, aerial parts
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Serial doses printed on polyester squares
Trial: 9339881
Drug: Venlafaxine XR
RxNorm normalized name: venlafaxine Extended Release Oral Capsule
DrugBank: Venlafaxine (DB00285)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Venlafaxine XR 75 mg once daily
Trial: 9339881
Drug: Venlafaxine IR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Venlafaxine IR 37.5 mg twice daily
Trial: 3518765
Drug: Atracurium 0.6
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Atracurium 0.6 mg kg‐1 (Group I, 20 patients)
Trial: 3518765
Drug: Atracurium 0.2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Atracurium 0.2 mg kg‐1 (Group II, 10 patients)
Trial: 29970072
Drug: Arctostaphylos uva‐ursi
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Arctostaphylos uva‐ursi (UU, bearberry extract arbutin) 105 mg, 3 times a day for 5 days
Trial: 29970072
Drug: Fosfomycin 3
RxNorm normalized name: fosfomycin 3000 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fosfomycin 3 g once
Trial: 25917376
Drug: Monthly structured
RxNorm normalized name: LIPID,STRUCTURED (FROM SUNFLOWER OIL)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Monthly structured pharmaceutical care visits delivered by pharmacists for 6 months
Trial: 20107144
Drug: Anthelmintic treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Anthelmintic treatment at 0 and 3 months
Trial: 20107144
Drug: Iron-fortified biscuits
RxNorm normalized name: INFANT FORMULA SMA IRON FORTIFIED CONC
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Iron-fortified biscuits providing an additional 20 mg iron/d as electrolytic iron 4 times/week
Trial: 15990345
Drug: Tidal breathing
RxNorm normalized name: cetylpyridinium chloride Mouthwash [Breath-Away]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tidal breathing method with capsaicin 0.4 micromol/L